Patents by Inventor Chagai Komlos

Chagai Komlos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix
    Patent number: 8961544
    Abstract: Patches comprising dry gelatin compositions.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: February 24, 2015
    Assignee: Lifebond Ltd.
    Inventors: Chagai Komlos, Guy Tomer, Maria Ziv, Orahn Preiss-Bloom, Thomas Bayer
  • Cross-linked compositions
    Patent number: 8703117
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: April 22, 2014
    Assignee: Lifebond Ltd.
    Inventors: Orahn Preiss Bloom, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • DRY COMPOSITION WOUND DRESSINGS AND ADHESIVES
    Publication number: 20130131701
    Abstract: Patches comprising dry gelatin compositions and methods of use and manufacture thereof.
    Type: Application
    Filed: August 5, 2011
    Publication date: May 23, 2013
    Applicant: LIFEBOND LTD.
    Inventors: Chagai Komlos, Guy Tomer, Maria Ziv, Orahn Preiss-Bloom, Thomas Bayer
  • Cross-linked compositions
    Patent number: 8367388
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: February 5, 2013
    Assignee: Lifebond Ltd.
    Inventors: Orahn Preiss Bloom, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • CROSS-LINKED COMPOSITIONS
    Publication number: 20120329132
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Application
    Filed: July 23, 2012
    Publication date: December 27, 2012
    Inventors: Orahn Preiss BLOOM, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber
  • CROSS-LINKED COMPOSITIONS
    Publication number: 20110110882
    Abstract: Improved compositions comprising a cross-linkable protein or polypeptide, and a non-toxic material which induces cross-linking of the cross-linkable protein. The compositions are optionally and preferably prepared in a non-phosphate buffer solvent. Optionally and preferably, the cross-linkable protein includes gelatin and any gelatin variant or variant protein as described herein. Optionally and preferably, the non-toxic material comprises transglutaminase (TG), which may optionally comprise any type of calcium dependent or independent transglutaminase, which may for example optionally be a microbial transglutaminase (mTG).
    Type: Application
    Filed: June 18, 2009
    Publication date: May 12, 2011
    Inventors: Orahn Preiss-Bloom, Ishay Attar, Natalie Iram, Chagai Komlos, Meir Haber